Politics

AstraZeneca has agreed to pay $110 million to settle two whistleblower lawsuits brought by the State of Texas that the company targeted the Texas Medicaid system with a fraudulent marketing scheme for its expensive and powerful atypical antipsychotic Seroquel.

Read the source article at tmcnet.com